SHIMOJO Nobutake
- Articles
- Involvement of peptidyl-prolyl isomerase Pin1 in the inhibitory effect of fluvastatin on endothelin-1-induced cardiomyocyte hypertrophy.
Sakai Satoshi; Shimojo Nobutake; Kimura Taizo; Tajiri Ka...
Life Sciences/102(2)/pp.98-104, 2014-05 - 心臓でのendothelin(ET)-2の発現変化は、ET-1の発現変化と相反するパターンをとる。 : ET-2の不全心における発現低下と、培養心筋細胞での低酸素曝露に対する発現上昇
柿沼 由彦; 後藤 勝年; 宮内 卓; 酒井 俊; 小林 勉; 下條 信威; 結城 幸一; 山口 巖; 杉下 靖郎
Japanese circulation journal/62(0)/p.421, 1998-02 - Left ventricular strain and transmural structural remodeling distribution in hypertensive heart disease
Ishizu T.; Seo Y.; Kameda Y.; Kimura T.; Shimojo N.; Xu D.; Mur...
EUROPEAN HEART JOURNAL/34(1)/pp.679-679, 2013-08 - A model of retinal ischemia-reperfusion injury in rats by subconjunctival injection of endothelin-1
Masuzawa K; Arai Subrina; Maeda S; Kaji Y; Oshika T; Zaedi S; S...
Experimental Biology and Medicine/231/pp.1085-1089, 2006-06 - Alterations of gene expressions of preproET-1 and ET receptors in brains of endotoxemic Sprague-Dawley rats
Shimojo N; Arai Subrina; Zaedi S; Maeda S; Gando S; Yamaguchi ...
Experimental Biology and Medicine/231/pp.1058-1063, 2006-06 - Alterations in gene expressions encoding preproET-1 and NOS in pulmonary tissue in endotoxemic rats
Zaedi S; Arai Subrina; Maeda S; Shimojo N; Yamaguchi I; Goto K...
Experimental Biology and Medicine/231/pp.992-996, 2006-06 - Altered expression of endothelin, vascular endothelial growth factor, and its receptor in hepatic tissue in endotoxemic rat
Zaedi S; Arai Subrina; Yamaguchi N; Shimojo N; Maeda S; Gando ...
Experimental Biology and Medicine/231/pp.1182-1186, 2006-06 - EPA effect on NOS gene expression and on NO level in endothelin-1-induced hypertrophied cardiomyocytes
Shimojo N; Arai Subrina; Zaedi S; Soma M; Kobayashi M; Maeda S...
Experimental Biology and Medicine/231/pp.913-918, 2006-06 - Changes in important apoptosis-related molecules in the endothelin-1-induced hypertrophied cardiomyocytes: effect of the pretreatment with eicosapentaenoic Acid
Shimojo N; Arai Subrina; Zaedi S; Soma M; Maeda S; Yamaguchi I...
Experimental Biology and Medicine/231/pp.932-936, 2006-06 - Effect of endothelin dual receptor antagonist on VEGF levels in streptozotocin-induced diabetic rat retina
Masuzawa K; Arai Subrina; Maeda S; Zaedi S; Shimojo N; Miyauch...
Experimental Biology and Medicine/231/pp.1090-1094, 2006-06 - Eicosapentaenoic acid prevents endothelin-1-induced cardiomyocyte hypertrophy in vitro through the suppression of TGF-beta 1 and phosphorylated JNK
Shimojo N; Arai Subrina; Zaedi S; Maeda S; Soma M; Aonuma K; Ya...
American Journal of Physiology-Heart and Circulatory Physiology/291(2)/pp.H835-H845, 2006-08 - Differential effects of selective endothelin type a receptor antagonist on the gene expression of vascular endothelial growth factor and its receptors in streptozotocin-induced diabetic heart
荒井 サブリナ; Zaedi S; Yamaguchi N; Maeda S; Shimojo N; Masuzawa K; ...
Experimental Biology and Medicine/231/pp.902-906, 2006-06 - Endothelin antagonism normalizes VEGF signaling and cardiac function in STZ-induced diabetic rat hearts
荒井 サブリナ; Zaedi S; Shimojo N; Iemitsu M; Masuzawa K; Yamaguchi ...
American Journal of Physiology-Endocrinology and Metabolism/292/pp.E1030-E1040, 2007-04 - Involvement of Endothelin-1 in Habitual Exercise-Induced Increase in Arterial Compliance
Maeda S; Sugawara J; Yoshizawa M; Otsuki T; Shimojo N; Arai Su...
Acta Physiologica (Oxf)/196(2)/pp.223-223, 2009-06 - A statin agent, pitavastatin, normalizes aberrant signaling of VEGF and function of the heart in the STZ-induced diabetic rat model.
Arai Subrina; Yamaguchi N; Iwashima Y; Shimojo Nobutake; Akte...
European Journal of Pharmacology, 2013-01 - Effects of Medium-chain Triglyceride (MCT) Application to SHR on Cardiac Function, Hypertrophy and Expression of Endothelin-1 mRNA and other Genes
Shimojo Nobutake; Miyauchi Takashi; Iemitsu Motoyuki; Iru...
J Cardiovasc Pharmacol/44(1)/pp.181-185, 2004-11 - Increased plasma levels of big-endothelin-2 and big-endothelin-3 in patients with end-stage renal disease.
Miyauchi Y; Sakai S; Maeda S; Shimojo N; Watanabe S; Honma S; K...
Life Sciences/91(13-14)/pp.729-732, 2012-1 - Suppressor of Cytokine Signaling 1 in Dendritic Cells Inhibits Myocardial Inflammation in Experimental Autoimmune Myocarditis
Tajiri Kazuko; Imanaka-Yoshida Kyoko; Hiroe Michiaki; Shimoj...
CIRCULATION RESEARCH/111(4::S), 2012-08 - Sterol Regulatory Element-Binding Protein-1 Is Involved in the Development of Angiotensin II-Induced Cardiac Fibrosis
Sakai Satoshi; Nakagawa Yoshimi; Shimojo Nobutake; Kim...
CIRCULATION RESEARCH/111(4::S), 2012-08 - ORGAN SPECIFIC EXPRESSION OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) IN LIPOPOLYSACCHARIDE (LPS)-INDUCED ENDOTOXEMIA
Jesmin Subrina; Yanagida Yuichiro; Wada Takeshi; Shimojo Nob...
CRITICAL CARE MEDICINE/40(12::S)/pp.U65-U65, 2012-12 - VEGF signaling is disrupted in the hearts of mice lacking estrogen receptor alpha
Jesmin S; Mowa CN; Sultana SN; Shimojo N; Togashi H; Iwas...
Eur J Pharmacol/641/pp.168-178, 2010-01 - Effects of Medium-chain Triglyceride (MCT) Application to SHR on Cardiac Function, Hypertrophy and Expression of Endothelin-1 mRNA and other Genes.
Shimojo N; Miyauchi T; Iemitsu M; Irukayama-Tomobe Y; Maeda S...
J Cardiovasc Pharmacol/44/pp.181-185, 2004-11 - Endothelin Antagonism Normalizes VEGF Signaling and Cardiac Function in STZ-Induced Diabetic Rat Hearts.
Jesmin S; Zaedi S; Shimojo N; Iemitsu M; Masuzawa K; Yama...
Am J Physiol Endocrinol Metab,/292/p.1030-1040, 2007-01 - Tenascin-C may aggravate left ventricular remodeling and function after myocardial infarction in mice.
Nishioka T; Onishi K; Shimojo N; Nagano Y; Matsusaka H; I...
Am J Physiol Heart Circ Physiol/298(3)/p.1072-1078, 2010-03 - Physician-pharmacist cooperation program for blood pressure control in patients with hypertension: a randomized-controlled trial.
Tobari H; Arimoto T; Shimojo N; Yuhara K; Noda H; Yamagis...
Am J Hypertens/23(10)/p.1144-1152, 2010-10 - more...
- Involvement of peptidyl-prolyl isomerase Pin1 in the inhibitory effect of fluvastatin on endothelin-1-induced cardiomyocyte hypertrophy.